PMS25 COST-EFFECTIVENESS OF RITUXIMAB (MABTHERA) COMPARED WITH TNF INHIBITORS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS (RA) IN POLAND
Abstract
Authors
R Plisko J Krzystek P Rys M Russel-Szymczyk M Szkultecka-Debek K Szamotulska